BMP-2 vs FGF2
Head-to-head comparison of BMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and FGF2 (Recombinant Human Fibroblast Growth Factor 2) — benefits, dosing, side effects, research data, and where to buy.
| Property | BMP-2 | FGF2 |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Recombinant Human Bone Morphogenetic Protein-2 | Recombinant Human Fibroblast Growth Factor 2 |
| Molecular Weight | 26000 Da | 17.2 kDa |
| Half-Life | short, localized exposure | minutes to <1 hour local |
| Amino Acids | 114 | 155 |
| Typical Dose | 1.5 mg/mL local implant | 1–10 µg/cm²/day |
| Route | Local/Implant | Topical |
| Purity | ≥98% | ≥98% |
| Studies Count | 1500 | 1200 |
| Research Status | Clinical | Clinical |
BMP-2 Benefits
- ✓promotes osteogenesis
- ✓supports nonunion healing
- ✓enhances scaffold-based repair
- ✓may improve defect fill
FGF2 Benefits
- ✓angiogenesis
- ✓fibroblast proliferation
- ✓granulation tissue formation
- ✓accelerated re-epithelialization
BMP-2 Dosing
local implantation on collagen sponge|single intraoperative dose|procedure-specific scaffold delivery
FGF2 Dosing
Topical spray/gel daily|intralesional microdoses in studies|short cycles during active repair
BMP-2 Side Effects
- ⚠local inflammation
- ⚠ectopic bone formation
- ⚠edema
FGF2 Side Effects
- ⚠local swelling
- ⚠pain
- ⚠fibroblast overgrowth/scarring
- ⚠theoretical malignancy concern
Research Overview
BMP-2
rhBMP-2 has strong clinical and translational literature for bone regeneration, spinal fusion, and defect repair. Its use is primarily local because systemic exposure is not the intended mechanism.
FGF2
FGF2 has extensive preclinical and clinical literature for skin ulcers, burns, and postsurgical repair, largely through angiogenic and mesenchymal-cell signaling. It remains one of the most studied repair factors for improving tissue perfusion and remodeling.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.